Ind Swift Limited (INDSWFTLTD) | Stock Overview & Key Data

Ind Swift Limited | Small-cap | Healthcare

₹15.71

5.79%

Ind Swift Limited vs Sun Pharmaceutical Ind Swift Limited vs Divi's Laboratories Ind Swift Limited vs Sun Pharma Advanced Ind Swift Limited vs Sequent Scientific Ind Swift Limited vs Aarti Drugs Ind Swift Limited vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Ind Swift Limited Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Ind Swift Limited	Healthcare Sector	NIFTY 50
1 Week	-1.57%	N/A	N/A
1 Month	-4.61%	N/A	N/A
3 Months	16.72%	N/A	N/A
6 Months	7.90%	N/A	N/A
1 Year	-32.96%	N/A	N/A
3 Years	59.19%	N/A	N/A
5 Years	356.81%	N/A	N/A

Stock Range

Today's Range

Low: ₹15.15 High: ₹17.82

on August 13, 2025

52 Week Range

Low: ₹12.00 High: ₹34.70

on May 7, 2025

on January 1, 2025

All-Time High: ₹88.00 on August 29, 2005

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR850.9M

EPS i 52.33

P/E Ratio (TTM) i 0.30

Forward P/E i N/A

P/B Ratio i N/A

PEG Ratio i N/A

Div. Yield i N/A

ROE i -70.45%

Beta i -0.730

Debt to Equity i -2.17

Financial Highlights

Profitability

Gross Margin i 50.91%

Operating Margin i -6.94%

Profit Margin i 55.01%

Returns and Earnings

Return on Assets (TTM) i -0.05%

Return on Equity (TTM) i -70.45%

EBITDA i INR418.7M

Net Income (TTM) i INR2.8B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR95.12

Quarterly Revenue Growth (YoY) i 7.00%

Quarterly Earnings Growth (YoY) i 583.50%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Ind Swift Limited INDSWFTLTD	850.93M Small-cap	-1.57%	-4.61%	16.72%	7.90%	-52.75%	-32.96%	59.19%	356.81%
Sun Pharmaceutical SUNPHARMA	3.90T Large-cap	1.69%	-1.04%	-6.06%	-1.23%	-15.78%	-14.14%	83.37%	204.14%
Divi's Laboratories DIVISLAB	1.61T Large-cap	-1.93%	0.18%	-9.51%	8.85%	-1.16%	9.16%	67.96%	79.48%
Sun Pharma Advanced SPARC	45.84B Small-cap	-1.13%	-0.36%	-14.95%	11.43%	-29.29%	-37.37%	-36.02%	-21.04%
Sequent Scientific SEQUENT	45.94B Small-cap	8.58%	5.50%	-1.45%	28.86%	1.03%	5.28%	69.53%	24.03%
Aarti Drugs AARTIDRUGS	46.55B Small-cap	4.86%	0.60%	5.09%	35.50%	8.09%	-6.21%	9.19%	-33.63%

Ownership & Short Interest

Insider Ownership i 65.23%

Institutional Ownership i 0.00%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 106K

Average 90-Day Volume i 187K

Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of , please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: -1.57%
1 Month: -4.61%
3 Months: 16.72%
1 Year: -32.96%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is INDSWFTLTD's 52-week high and low?

In the last 52 weeks, Ind Swift Limited reached a high of ₹34.70 (on January 1, 2025) and a low of ₹12.00 (on May 7, 2025).

What is the market cap and P/E ratio for INDSWFTLTD?

Curious about Ind Swift Limited's size and valuation? Its market capitalization stands at 850.93M. When it comes to valuation, the P/E ratio (trailing twelve months) is 0.30, and the forward P/E (looking ahead) is N/A.

Does INDSWFTLTD pay dividends? If so, what's the yield?

As for dividends, Ind Swift Limited isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Ind Swift Limited's main competitors or similar companies to consider before investing?

When looking at Ind Swift Limited, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sun Pharmaceutical SUNPHARMA	3.90T	Healthcare	Drug Manufacturers - Specialty & Generic	-14.14%	83.37%
Divi's Laboratories DIVISLAB	1.61T	Healthcare	Drug Manufacturers - Specialty & Generic	9.16%	67.96%
Sun Pharma Advanced SPARC	45.84B	Healthcare	Drug Manufacturers - Specialty & Generic	-37.37%	-36.02%
Sequent Scientific SEQUENT	45.94B	Healthcare	Drug Manufacturers - Specialty & Generic	5.28%	69.53%
Aarti Drugs AARTIDRUGS	46.55B	Healthcare	Drug Manufacturers - Specialty & Generic	-6.21%	9.19%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Ind Swift Limited? (e.g., ROE, Debt/Equity)

To get a sense of Ind Swift Limited's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -70.45%, the Debt to Equity ratio from the most recent quarter is -2.17, and its Gross Profit Margin stands at 50.91%.

What is the recent revenue and earnings growth for INDSWFTLTD?

Looking at Ind Swift Limited's growth, its revenue over the trailing twelve months (TTM) was INR5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.00%, and quarterly earnings saw a YoY growth of 583.50%.

How much of INDSWFTLTD stock is held by insiders and institutions?

Wondering who owns Ind Swift Limited stock? Company insiders (like executives and directors) hold about 65.23% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.